<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Immunol Ther Exp (Warsz)</journal-id><journal-id journal-id-type="iso-abbrev">Arch. Immunol. Ther. Exp. (Warsz.)</journal-id><journal-title-group><journal-title>Archivum Immunologiae et Therapiae Experimentalis</journal-title></journal-title-group><issn pub-type="ppub">0004-069X</issn><issn pub-type="epub">1661-4917</issn><publisher><publisher-name>Springer Basel</publisher-name><publisher-loc>Basel</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25205210</article-id><article-id pub-id-type="pmc">4359282</article-id><article-id pub-id-type="publisher-id">312</article-id><article-id pub-id-type="doi">10.1007/s00005-014-0312-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Plasma Kynurenic Acid Concentration in Patients Undergoing Cardiac Surgery: Effect of Anaesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kotlinska-Hasiec</surname><given-names>Edyta</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Nowicka-Stazka</surname><given-names>Patrycja</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Parada-Turska</surname><given-names>Jolanta</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Stazka</surname><given-names>Krzysztof</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Stazka</surname><given-names>Janusz</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Zadora</surname><given-names>Przemyslaw</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Dabrowski</surname><given-names>Wojciech</given-names></name><address><email>w.dabrowski5@yahoo.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Anaesthesiology and Intensive Therapy, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland </aff><aff id="Aff2"><label/>Department of Endocrinology, Medical University of Lublin, Lublin, Poland </aff><aff id="Aff3"><label/>Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland </aff><aff id="Aff4"><label/>Department of Cardiology, Medical University of Lublin, Lublin, Poland </aff><aff id="Aff5"><label/>Department of Cardiac Surgery, Medical University of Lublin, Lublin, Poland </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="ppub"><year>2015</year></pub-date><volume>63</volume><issue>2</issue><fpage>129</fpage><lpage>137</lpage><history><date date-type="received"><day>24</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2014</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p></license></permissions><abstract id="Abs1"><p>Increases in plasma kynurenic acid (KYNA) concentration relate to the severity of inflammation. The aim of this study was to analyse changes in plasma KYNA concentration and neutrophil/lymphocyte ratio (NLR) in cardiac surgery patients. Additionally, the effect of anaesthesia was analysed. Adult cardiac surgery patients under intravenous general anaesthesia were studied. Additionally, some patients received sevoflurane (SEV) prior to cardiopulmonary bypass. Plasma KYNA concentration and NLR were measured before anaesthesia, just after surgery and on postoperative days 1, 2 and 3. Patients were assigned to two groups: patients who did not receive SEV (NonSEV group) and patients who received SEV (SEV group). Forty-three patients were studied. Twenty-four of them received SEV. KYNA increased immediately after surgery and remained elevated through postoperative day 3 in the NonSEV group, whereas it was similar to the preoperative concentration in the SEV group. NLR increased immediately after surgery in both groups, and higher values were noted in the NonSEV group than in the SEV group at postoperative days 2 and 3. Plasma KYNA concentration correlated with NLR in the NonSEV group. Cardiac surgery caused an increase in NLR. Plasma KYNA increased in the NonSEV group and correlated with NLR. Administration of SEV inhibited the increase in KYNA, most likely due to its anti-inflammatory properties.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Kynurenic acid</kwd><kwd>Neutrophil/lymphocyte ratio</kwd><kwd>Sevoflurane</kwd><kwd>Cardiac surgery</kwd><kwd>General anaesthesia</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="intro"><title>Introduction</title><p>Kynurenic acid (KYNA) is one of the end products of tryptophan formed in the kynurenine pathway. In the first step of this process, tryptophan is oxygenised by tryptophan 2,3 dioxygenase (TDO) or indoleamine 2,3-dioxygenase (IDO) into kynurenine, which is then transformed by kynurenine aminotransferases into KYNA (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Physiological concentration of the human plasma KYNA ranges between 25 and 60&#x000a0;nM (Bender <xref ref-type="bibr" rid="CR4">1982</xref>; Forrest et al. <xref ref-type="bibr" rid="CR19">2006</xref>; Turski et al. <xref ref-type="bibr" rid="CR62">2013</xref>). Several pathologies affect plasma KYNA concentration. It becomes elevated following brain ischaemia and stroke or in schizophrenia, whereas it decreases during Alzheimer&#x02019;s disease, multiple sclerosis, epilepsy or depression (Angus et al. <xref ref-type="bibr" rid="CR1">2001</xref>; Darlington et al. <xref ref-type="bibr" rid="CR15">2007</xref>; Hartai et al. <xref ref-type="bibr" rid="CR26">2007</xref>; Laupland et al. <xref ref-type="bibr" rid="CR36">2004</xref>; N&#x000e9;math et al. <xref ref-type="bibr" rid="CR43">2005</xref>; Nilsson et al. <xref ref-type="bibr" rid="CR44">2005</xref>; Stone et al. <xref ref-type="bibr" rid="CR58">2003</xref>). Moreover, a lot of studies underline the neuroprotective properties of KYNA in animals with experimental brain injury
(Darlington et al. <xref ref-type="bibr" rid="CR15">2007</xref>; Gell&#x000e9;rt et al. <xref ref-type="bibr" rid="CR22">2013</xref>; Sas et al. <xref ref-type="bibr" rid="CR51">2008</xref>). KYNA production is also elevated during a bacterial or viral inflammation, an autoimmune disease and after a severe trauma (Forrest et al. <xref ref-type="bibr" rid="CR19">2006</xref>; Hartai et al. <xref ref-type="bibr" rid="CR26">2007</xref>; Scott et al. <xref ref-type="bibr" rid="CR53">2009</xref>; Zeden et al. <xref ref-type="bibr" rid="CR68">2010</xref>). Increases in plasma tryptophan metabolites have also been observed in patients undergoing elective abdominal or cardiac surgery (Forrest et al. <xref ref-type="bibr" rid="CR21">2011</xref>; Marfella et al. <xref ref-type="bibr" rid="CR42">1999</xref>). Perioperative increases in plasma cytokine concentrations following surgery-related inflammatory response may affect plasma KYNA concentration. Interestingly, the severity of surgery-related inflammatory response appears to depend on perioperative treatment and on type of anaesthesia. Some authors documented a significant reduction in plasma levels of pro-inflammatory cytokines following ketamine or propofol administration (Blum and Zuo <xref ref-type="bibr" rid="CR5">2013</xref>; Gokcinar et al. <xref ref-type="bibr" rid="CR25">2013</xref>). Similarly, volatile anaesthetics present anti-inflammatory effect reducing pro-inflammatory cytokine production in the kidney, respiratory system and nervous system (Li et al. <xref ref-type="bibr" rid="CR37">2013a</xref>, <xref ref-type="bibr" rid="CR38">b</xref>; Kim et al. <xref ref-type="bibr" rid="CR33">2011</xref>). Moreover, the inhalation of sevoflurane (SEV) at 1.0 minimal anaesthetic concentration (MAC) significantly attenuates concentrations of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-&#x003b1; and interleukin (IL)-1&#x003b2; in plasma of septic shock rats (Hofstetter et al. <xref ref-type="bibr" rid="CR28">2007</xref>). Based on these observations, we can assume that SEV anaesthesia may affect plasma KYNA concentration via an attenuation of a surgery-related inflammatory response, but this effect has not been examined yet.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Kynurenine pathway</p></caption><graphic xlink:href="5_2014_312_Fig1_HTML" id="MO1"/></fig></p><p>The neutrophil/lymphocyte ratio (NLR) is a potentially interesting marker of inflammation. A greater perioperative neutrophil count may reflect subclinical inflammation, and lymphocyte count relates to physiological stress and is a surrogate marker for general health (de Jager et al. <xref ref-type="bibr" rid="CR16">2010</xref>; Zahorec <xref ref-type="bibr" rid="CR67">2001</xref>). Therefore, NLR can be proposed as a simple marker of inflammation. Many authors describe NLR as a marker of postoperative outcome (Azab et al. <xref ref-type="bibr" rid="CR2">2013</xref>; Gibson et al. <xref ref-type="bibr" rid="CR23">2007</xref>, <xref ref-type="bibr" rid="CR24">2010</xref>). Both an elevated neutrophil count and a reduced lymphocyte count are associated with a worse outcome after cardiac surgery (Azab et al. <xref ref-type="bibr" rid="CR2">2013</xref>; Gibson et al. <xref ref-type="bibr" rid="CR23">2007</xref>). Elevated NLR is associated with an increased risk of postoperative atrial fibrillation, which may correspond to a greater severity of postoperative inflammation (Gibson et al. <xref ref-type="bibr" rid="CR24">2010</xref>). Based on this observation, we hypothesised that NLR correlates with plasma KYNA concentration.</p><p>The aim of the present study was to analyse the changes in plasma KYNA concentration and in NLR in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Additionally, the effects of SEV, a pleasant-smelling volatile anaesthetic, widely used for induction and maintenance of general anaesthesia, on plasma KYNA concentration and NLR were analysed.</p></sec><sec id="Sec2" sec-type="methods"><title>Patients and Methods</title><p>The study was approved by the Committee for Bioethics at the Medical University of Lublin, and written informed consent was obtained from all patients involved. Patients scheduled for elective cardiac surgery due to stable angina pectoris (CABG) or aortic/mitral valve in sufficiency were included. The exclusion criteria encompassed the following: any current neurological disease or history of neurological disorders, brain surgery, severe head trauma, significant carotid artery stenosis, chronic respiratory disease, chronic renal insufficiency, chronic renal failure or an EuroScore higher than 8.</p><sec id="Sec3"><title>Anaesthesia and Surgery</title><p>One day before surgery, all participants received the same premedication with lorazepam (Lorafen, Polfa, Inc., Poland) and morphine hydrochloride (morphinum hydrochloricum, Polfa, Inc., Poland). Anaesthesia was induced using fentanyl (Fentanyl, Polfa, Poland) midazolam (Sopodorm, Polfa, Inc., Poland) and etomidate (Etomidate, Braun, Germany). Muscle relaxation was obtained with a single dose of pancuronium (Pavulon, Pancuronium, Jelfa, Poland). After tracheal intubation, all patients were ventilated using intermittent positive pressure ventilation with a mixture of air and oxygen. Parameters were adjusted to maintain normocapnia, which was controlled by blood gas analysis. Anaesthesia was maintained throughout the procedure using remifentanil (Ultiva, GlaxoSmithKline, Plc., UK) and propofol (Diprivan, Astra-Zeneca, Ltd., USA). Additionally, prior to initiating CPB, some patients received SEV (Sevorane, Abbott, Plc., UK) at a dose of 0.5&#x02013;1.0 of the MAC. The concealed envelope method was used for SEV administration. The dose of anaesthetic administered depended on the patient&#x02019;s haemodynamic status. Intra-operative hypertension was treated with a single bolus of remifentanil or propofol. In patients not responding adequately to anaesthesia, a single intravenous dose of urapidil (Ebrantil, Takeda GmbH, Germany) was used. Tachycardia was treated with beta-blockers.</p><p>Prior to CPB, heparinum sulphuricum (Heparin, Polfa, Poland) was administered, and the activated clotting time was controlled up to 400&#x000a0;s. For CPB, standard cannulation of the ascending aorta and inferior vena cava was performed through the right atrium. During CPB, circulation and ventilation were maintained with the heart&#x02013;lung machine S III (St&#x000f6;ckert, GmbH, Germany), and the mean arterial pressure was kept between 45 and 105&#x000a0;mmHg. In all patients, the volume of priming was constant and consisted of 1,000&#x000a0;ml of Ringer&#x02019;s solution (Ringer, Baxter, Inc., Sabinanico, Spain), 500&#x000a0;ml of 6&#x000a0;% solution of hydroxyethylated starch (Voluven, Fresenius-Kabi, Inc., Poland), 250&#x000a0;ml of 20&#x000a0;% mannitol (Mannitol, Fresenius-Kabi, Poland), 20&#x000a0;ml of sodium hydroxycarbonate (natrium bicarbonatum, Polfarma, Inc., Poland) and 75&#x000a0;mg of heparinum sulphuricum. Cardiopulmonary bypass was instituted with pulsatile flow of 2.4&#x000a0;l/min/m<sup>2</sup> of body surface area. After traditional aortic clamping, myocardial viability was preserved with antegrade hyperkalaemic warm blood cardioplegia. During mild hypothermic CPB, the mean arterial pressure, haematocrit and blood gas parameters as well as the lactate, sodium and potassium levels were measured. Distal anastomoses were performed during cardioplegic arrest, whereas proximal anastomoses were performed with resumed perfusion and a side-biting clamp. Mediastinal blood was sucked into the cardiotomy reservoir of the heart&#x02013;lung machine. The last suction was performed 10&#x000a0;min before the completion of CPB. In all cases, separation from the heart&#x02013;lung machine was uneventful, and intra-aortic counterpulsation was not necessary. In patients requiring inotropic support, dobutamine (Dobuject, Bayer-Schering, Gmbh, Germany) or dobutamine and norepinephrine (Levonor, Polfa, Poland) infusion were used at doses that depended on the patient&#x02019;s haemodynamic status. The effect of heparin was reversed by an adequate dose of protamine sulphate (Protaminum sulphuricum, Biomed, Inc., Poland). During surgery and in the early postoperative period, patients received an infusion of mixture of potassium chloride and magnesium sulphate.</p><p>After surgery, patients were sent to the postoperative intensive care unit (PICU). All of them were ventilated using synchronised intermittent mandatory ventilation with pressure support. Patients were extubated 8&#x02013;12&#x000a0;h after surgery and were transferred from the PICU on the second or third postoperative day.</p><p>After the induction of anaesthesia and prior to the beginning of CPB, 500&#x000a0;ml of 6&#x000a0;% hydroxyethyl starch (6&#x000a0;% HAES, Polfa, Poland) was infused. After CPB, haematologic parameters were monitored. None of the patients required massive fluid resuscitation, and the type and dose of administered fluids depended upon the patient&#x02019;s haemodynamic status. Intravascular fluid insufficiency during the early postoperative period was treated by supplementation with gelatine preparations or electrolyte fluids (PWE and Ringer, Polfa, Poland).</p></sec><sec id="Sec4"><title>Study Protocol and Patient Distribution</title><p>Plasma KYNA concentration and NLR were measured at five time points: before anaesthesia and surgery, just after completion of surgery and on the morning of postoperative days 1, 2 and 3. The blood samples for plasma KYNA concentration measurement were collected from the radial artery and immediately centrifuged (2,500&#x000a0;r/min); obtained plasma was frozen at &#x02212;20&#x000a0;&#x000b0;C. Plasma KYNA was measured fluorometrically. Plasma was deproteinated with 50&#x000a0;% trichloroacetic acid and centrifuged. Supernatant was applied on cation-exchange resin (Dowex 50&#x000a0;W+, Sigma-Aldrich, MO, USA). Eluted KYNA was subjected to high-performance liquid chromatography (HPLC) (Hewlett Packard 1050 HPLC system: ESA catecholamine HR-30, 3&#x000a0;&#x003bc;m, C<sub>18</sub> reverse-phase column) and quantified fluorometrically (Hewlett Packard 1046A fluorescence detector: excitation 344&#x000a0;nm, emission 398&#x000a0;nm) (Shibata <xref ref-type="bibr" rid="CR54">1988</xref>). The KYNA concentrations are expressed in nM.</p><p>Based on the volatile anaesthetic administration, patients were assigned to two groups: patients who did not receive SEV (NonSEV group) and patients who received SEV before the beginning of CPB (SEV group).</p></sec><sec id="Sec5"><title>Statistics</title><p>Means and standard deviations (SD) were calculated for parametric data. The value at time point 1 was regarded as baseline. The unpaired Student&#x02019;s <italic>t</italic> test was used to analyse variables with a normal distribution. Non-parametric data were statistically analysed using the Wilcoxon signed-rank test and the Kruskal&#x02013;Wallis ANOVA test for initial detection of differences. <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 was considered statistically significant. Sample size was determined by Statistica 9 software. The power of all statistical tests was determined by G*Power software (1&#x02013;&#x003b2;).</p></sec></sec><sec id="Sec6" sec-type="results"><title>Results</title><p>Forty-three consecutive patients (30 male and 13 female) were examined. In all cases, weaning from the heart&#x02013;lung machine was uneventful and intra-aortal counterpulsation was not necessary. After CPB, none of the patients required an aggressive fluid therapy.</p><p>The mean age of all patients was 63&#x000a0;&#x000b1;&#x000a0;12&#x000a0;years. It was 63&#x000a0;&#x000b1;&#x000a0;13&#x000a0;years in patients who did not receive SEV and 62&#x000a0;&#x000b1;&#x000a0;12&#x000a0;years in patients who received SEV before CPB. There was no significant difference in body mass index between both studied groups (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Moreover, there was no difference in mean duration of anaesthesia, surgery, CPB or aorta clamping (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Twenty-four patients (55.8&#x000a0;%) received SEV before the CPB.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Patient demographic data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Study population</th><th align="left">NonSEV group (<italic>n</italic>&#x000a0;=&#x000a0;19)</th><th align="left">SEV group (<italic>n</italic>&#x000a0;=&#x000a0;24)</th><th align="left">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Male</td><td align="left">30</td><td align="left">12</td><td align="left">18</td><td char="." align="char">&#x02013;</td></tr><tr><td align="left">Female</td><td align="left">13</td><td align="left">7</td><td align="left">6</td><td char="." align="char">&#x02013;</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="left">28.44&#x000a0;&#x000b1;&#x000a0;5.53</td><td align="left">28.50&#x000a0;&#x000b1;&#x000a0;5.42</td><td align="left">28.37&#x000a0;&#x000b1;&#x000a0;5.83</td><td char="." align="char">0.91</td></tr><tr><td align="left" colspan="5">Duration of (min)</td></tr><tr><td align="left">&#x000a0;Anaesthesia</td><td align="left">282&#x000a0;&#x000b1;&#x000a0;68</td><td align="left">291&#x000a0;&#x000b1;&#x000a0;79</td><td align="left">275&#x000a0;&#x000b1;&#x000a0;60</td><td char="." align="char">0.59</td></tr><tr><td align="left">&#x000a0;Surgery</td><td align="left">222&#x000a0;&#x000b1;&#x000a0;65</td><td align="left">235&#x000a0;&#x000b1;&#x000a0;74</td><td align="left">212&#x000a0;&#x000b1;&#x000a0;60</td><td char="." align="char">0.23</td></tr><tr><td align="left">&#x000a0;CPB</td><td align="left">112&#x000a0;&#x000b1;&#x000a0;59</td><td align="left">124&#x000a0;&#x000b1;&#x000a0;74</td><td align="left">103&#x000a0;&#x000b1;&#x000a0;45</td><td char="." align="char">0.54</td></tr><tr><td align="left">&#x000a0;AC</td><td align="left">70&#x000a0;&#x000b1;&#x000a0;39</td><td align="left">74&#x000a0;&#x000b1;&#x000a0;44</td><td align="left">66&#x000a0;&#x000b1;&#x000a0;36</td><td char="." align="char">0.56</td></tr></tbody></table><table-wrap-foot><p>
<italic>BMI</italic> body mass index, <italic>AC</italic> aorta clamping, <italic>CPB</italic> cardiopulmonary bypass, <italic>SEV</italic> sevoflurane. <italic>NonSEV group</italic> patients who were anesthetised intravenously, <italic>SEV group</italic> patients who were anesthetised intravenously and received SEV inhalation before CPB</p></table-wrap-foot></table-wrap></p><p>Before anaesthesia surgery, there was no statistically significant difference in plasma KYNA concentrations between NonSEV and SEV groups [median (quartile 1; quartile 3): 17.51&#x000a0;nM (11.91; 23.25) in the NonSEV group vs. 13.24&#x000a0;nM (8.73; 21.27) in the SEV group]. In the NonSEV group, increased KYNA was detected in plasma obtained immediately after completion of the surgical procedure and 1, 2 and 3&#x000a0;days thereafter. In the SEV group, plasma KYNA concentration was unaffected during postoperative period (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Moreover, plasma KYNA was significantly lower in the SEV group than in the NonSEV group immediately after surgery and on the postoperative days 1, 2 and 3 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Changes in plasma KYNA concentration [median (quartile 1 and 3)] in patients who were anaesthetised intravenously and did not receive volatile anaesthetic (sevoflurane) prior to cardiopulmonary bypass (CPB) (NonSEV group) and patients who were anaesthetised intravenously and received sevoflurane (SEV group). Time points: <italic>1</italic> before anaesthesia and surgery (baseline); <italic>2</italic> just after surgery; <italic>3</italic> on the morning of postoperative day 1; <italic>4</italic> on the morning of postoperative day 2; and <italic>5</italic> on the morning of postoperative day 3. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 compared with baseline in the NonSEV group (Wilcoxon test). <sup><bold>&#x02021;</bold></sup>
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, <sup><bold>&#x02021;&#x02021;</bold></sup>
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, NonSEV group vs. SEV group</p></caption><graphic xlink:href="5_2014_312_Fig2_HTML" id="MO2"/></fig></p><p>The value of NLR increased immediately after surgery in both groups, and significantly higher values were noted on the morning of postoperative days 2 and 3 (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). There was an overall correlation between plasma KYNA concentration and NLR in the NonSEV group (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001, <italic>r</italic>&#x000a0;=&#x000a0;0.46; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Moreover, plasma KYNA concentration strongly correlated with NLR on the postoperative days 1 and 2 (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, <italic>r</italic>&#x000a0;=&#x000a0;0.56 and <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, <italic>r</italic>&#x000a0;=&#x000a0;0.5, respectively) and moderately on the postoperative day 3 in the NonSEV group (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, <italic>r</italic>&#x000a0;=&#x000a0;0.47).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>The analysis of changes in neutrophil/lymphocyte ratio in cardiac surgery patients only anaesthetised intravenously (NonSEV group) and patients who were anaesthetised intravenously and received sevoflurane (SEV) at a dose of 0.5&#x02013;1.0 of the minimal anaesthetic concentration, prior to initiating cardiopulmonary bypass (SEV group)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Patients</th><th align="left" rowspan="2">Parameter</th><th align="left" colspan="5">Time point</th></tr><tr><th align="left">1</th><th align="left">2</th><th align="left">3</th><th align="left">4</th><th align="left">5</th></tr></thead><tbody><tr><td align="left">NonSEV group</td><td align="left">Median (quartile 1 and 3)</td><td align="left">3.12 (2.47&#x02013;4.5)</td><td align="left">10.8* (7.07&#x02013;15.15)</td><td align="left">9.9* (6.7&#x02013;14.61)</td><td align="left">10.52* (6.32&#x02013;13.73)</td><td align="left">8.13* (6.38&#x02013;14.4)</td></tr><tr><td align="left">SEV group</td><td align="left">Median (quartile 1 and 3)</td><td align="left">2.49 (2&#x02013;3.13)</td><td align="left">11.78* (6.26&#x02013;15.21)</td><td align="left">10.56* (7.57&#x02013;13.75)</td><td align="left">7.6* (6.71&#x02013;9.01)</td><td align="left">6.85* (5.47&#x02013;8.08)</td></tr><tr><td align="left" colspan="2">Intergroup differences (<italic>p</italic>)</td><td align="left">0.33</td><td align="left">0.52</td><td align="left">0.52</td><td align="left">0.001</td><td align="left">0.02</td></tr></tbody></table><table-wrap-foot><p>Time points: <italic>1</italic> before anaesthesia and surgery (baseline), <italic>2</italic> just after surgery, <italic>3</italic> on the morning of postoperative day 1, <italic>4</italic> on the morning of postoperative day 2, and <italic>5</italic> on the morning of postoperative day 3</p><p>* <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001 compared with baseline in the NonSEV group (Wilcoxon test)</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>The overall correlation between plasma KYNA concentration and neutrophil/lymphocyte ratio (NRL) in patients who were anesthetised intravenously (NonSEV group) (Spearman correlation test). In the SEV group, plasma KYNA concentration did not correlate with NLR at consecutive time points, and there was no overall correlation between plasma KYNA concentration and NLR</p></caption><graphic xlink:href="5_2014_312_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p>This is the first study documenting the effect of SEV anaesthesia on plasma KYNA concentration in patients undergoing elective cardiac surgery with CPB and its correlation with NLR. We found that cardiac surgery resulted in an increase in plasma KYNA in patients anaesthetised intravenously. An increase in KYNA was recorded in blood obtained immediately after completion of the surgical procedure and persisted until day 3 of observation. In these patients, plasma KYNA concentration correlated with NLR. In contrast, plasma KYNA concentration remained unaltered and did not correlate with NLR in patients who were anaesthetised intravenously and received SEV before the beginning of CPB.</p><p>Perioperative measurement of plasma KYNA concentration may provide a large amount of information and predispose final outcome. Persisted high plasma KYNA concentration has been noted in non-survived stroke traumatic patients and patients, who died after resuscitation (Darlington et al. <xref ref-type="bibr" rid="CR15">2007</xref>; Ploder et al. <xref ref-type="bibr" rid="CR45">2009</xref>; Ristagno et al. <xref ref-type="bibr" rid="CR47">2013</xref>). Significantly higher plasma KYNA concentration has been found in carotid surgery patients with postoperative neurological dysfunctions (Terlecki et al. <xref ref-type="bibr" rid="CR60">2014</xref>). KYNA has been also suggested as a marker of distress intolerance (Chiapelli et al. <xref ref-type="bibr" rid="CR10">2014</xref>). Noteworthy, increasing plasma KYNA concentration might predispose to sepsis and septic shock in patients after multi trauma and its level is related to sseverity of infection (Dabrowski et al. <xref ref-type="bibr" rid="CR14">2014</xref>; Schefold et al. <xref ref-type="bibr" rid="CR52">2009</xref>; Zeden et al. <xref ref-type="bibr" rid="CR68">2010</xref>). All of the above-mentioned pathologies may complicate early postoperative period in cardiac surgery patients.</p><p>The effect of cardiac surgery on plasma KYNA concentration has been poorly documented. Forrest et al. (<xref ref-type="bibr" rid="CR21">2011</xref>) reported no difference in blood KYNA in patients undergoing CABG during and up to 2&#x000a0;days after cardiac surgery and an increase in plasma KYNA on the sixth postoperative day. They also noted no changes in plasma KYNA in patients undergoing thoracic surgery. Importantly, all of the CABG patients were anaesthetised intravenously, and 71.4&#x000a0;% of them received volatile anaesthetics. All patients undergoing thoracic surgery were anaesthetised intravenously, and 50&#x000a0;% of them received isoflurane (Forrest et al. <xref ref-type="bibr" rid="CR21">2011</xref>). It is noteworthy that the effect of anaesthesia on plasma KYNA was not analysed in that study.</p><p>Our finding is in good agreement with that of Forrest et al. (<xref ref-type="bibr" rid="CR21">2011</xref>). In our study, plasma KYNA did not change in patients who received a volatile anaesthetic, SEV, before the beginning of CPB. In contrast to Forrest et al. (<xref ref-type="bibr" rid="CR21">2011</xref>), we found that cardiac surgery increased the KYNA concentration in patients anaesthetised intravenously and that KYNA was significantly higher than in patients who received SEV. Therefore, we can infer that cardiac surgery increases plasma KYNA and the use of volatile anaesthetic blocks this effect.</p><p>An increase in plasma KYNA recorded in patients anaesthetised intravenously may result from surgery-induced inflammatory response. Raised blood KYNA has been found in septic patients (Dabrowski et al. <xref ref-type="bibr" rid="CR14">2014</xref>; Schefold et al. <xref ref-type="bibr" rid="CR52">2009</xref>; Zeden et al. <xref ref-type="bibr" rid="CR68">2010</xref>), HIV-1 infection (Heyes et al. <xref ref-type="bibr" rid="CR27">1992</xref>), chronic kidney disease (Schefold et al. <xref ref-type="bibr" rid="CR52">2009</xref>), stroke patients (Darlington et al. <xref ref-type="bibr" rid="CR15">2007</xref>), after severe brain injury (Mackay et al. <xref ref-type="bibr" rid="CR40">2006</xref>) and cardiac arrest (Ristagno et al. <xref ref-type="bibr" rid="CR47">2013</xref>). Moreover, increased salivary KYNA concentration has been observed after acute physiological stress (Chiapelli et al. <xref ref-type="bibr" rid="CR10">2014</xref>). KYNA is regarded as an end-product of one of the branches of the kynurenine pathway, which is the main pathway of tryptophan metabolism. More than 90&#x000a0;% of plasma tryptophan is metabolised via the kynurenine pathway (Bender <xref ref-type="bibr" rid="CR4">1982</xref>). This process strongly depends on IDO and/or TDO activity. TDO has been found primarily in the liver and is activated by high tryptophan concentration and corticosteroids (Bender <xref ref-type="bibr" rid="CR4">1982</xref>; Braidy et al. <xref ref-type="bibr" rid="CR7">2011</xref>; Ruddick et al. <xref ref-type="bibr" rid="CR50">2006</xref>; Turski et al. <xref ref-type="bibr" rid="CR62">2013</xref>). IDO has been identified in brain and liver as well as in monocytes, macrophages, fibroblasts, dendritic cells and microglia. It is activated by several inflammatory mediators, such as TNF-&#x003b1;, IL-1, IL-2, IL-6, IL-23, interferon (IFN)-&#x003b1; and IFN-&#x003b3;. IFN-&#x003b3; is considered the most powerful activating factor (Bender <xref ref-type="bibr" rid="CR4">1982</xref>; Boasso et al. <xref ref-type="bibr" rid="CR6">2008</xref>; Braidy et al. <xref ref-type="bibr" rid="CR7">2011</xref>; Kidani et al. <xref ref-type="bibr" rid="CR32">2005</xref>; Song et al. <xref ref-type="bibr" rid="CR56">2013</xref>; Turski et al. <xref ref-type="bibr" rid="CR62">2013</xref>; Zitta et al. <xref ref-type="bibr" rid="CR69">2010</xref>). IDO activity stimulated by cytokines leads to a substantial increase in the level of tryptophan catabolites, including KYNA. Interestingly, plasma TNF-&#x003b1;, IL-1&#x003b2;, IL-6 and IL-10 and IFN-&#x003b3; increase following CPB (Codaccioni et al. <xref ref-type="bibr" rid="CR11">2009</xref>; Thal et al. <xref ref-type="bibr" rid="CR61">2012</xref>; Wang et al. <xref ref-type="bibr" rid="CR64">2010</xref>). Additionally, some authors have noted similarities between endotoxin-induced immune defect and cardiac surgery (Codaccioni et al. <xref ref-type="bibr" rid="CR11">2009</xref>). This inflammatory response is initiated by surgical trauma, blood contact with artificial surfaces in CPB circuit and ischemia&#x02013;reperfusion injury, and the degree of inflammatory response corresponds to postoperative outcome, including neuropsychological disorders (Symons and Myles <xref ref-type="bibr" rid="CR59">2006</xref>; Yue et al. <xref ref-type="bibr" rid="CR66">2008</xref>). In the present study, we observed an overall correlation between plasma KYNA concentration and NLR, a marker of inflammation (de Jager et al. <xref ref-type="bibr" rid="CR16">2010</xref>; Gibson et al. <xref ref-type="bibr" rid="CR24">2010</xref>; Zahorec <xref ref-type="bibr" rid="CR67">2001</xref>), in the NonSEV group. Moreover, we noted a strong correlation between plasma KYNA concentration and NLR in the early postoperative period, when the inflammatory response was the most intense. Therefore, we can assume that the postoperative increase in plasma KYNA is a result of CPB-related inflammatory response, though further studies are required to support our findings and this hypothesis.</p><p>An inflammation-caused increase in plasma KYNA may be confirmed by its correlation with NLR in patients anaesthetised intravenously. Lymphocytopenia and neutrophilia are physiological responses to inflammation in several pathologies. This so-called neutrophil&#x02013;lymphocyte stress factor is a well-documented marker describing the severity of disease and outcome measured by Acute Physiology and Chronic Health Evaluation II and Sepsis-related Organ Failure Assessment scores (Hwang et al. <xref ref-type="bibr" rid="CR30">2012</xref>; Zahorec <xref ref-type="bibr" rid="CR67">2001</xref>). Moreover, NLR is considered an independent predictor of bacteraemia and severity of inflammation in several pathologies (de Jager et al. <xref ref-type="bibr" rid="CR16">2010</xref>; Shiny et al. <xref ref-type="bibr" rid="CR55">2014</xref>). NLR often increases following cardiac surgery (Azab et al. <xref ref-type="bibr" rid="CR2">2013</xref>; Gibson et al. <xref ref-type="bibr" rid="CR23">2007</xref>, <xref ref-type="bibr" rid="CR24">2010</xref>). NLR is also a sensitive marker of inflammation predicting postoperative atrial fibrillation in cardiac surgery patients. Interestingly, Brouns et al. (<xref ref-type="bibr" rid="CR9">2010</xref>) found a correlation between tryptophan oxidation and NLR in stroke patients. They concluded that tryptophan metabolism strictly correlated with the stroke-related inflammatory response measured by C-reactive protein, erythrocyte sedimentation rate and NLR. They did not analyse a relationship between KYNA and NLR ratio, but they presented a similar trend of changes in plasma KYNA concentration and NLR. A relation between NLR and plasma KYNA concentration was observed by Terlecki et al. (<xref ref-type="bibr" rid="CR60">2014</xref>), who analysed changes in plasma KYNA concentration and NLR and found a strong correlation between mentioned parameters. In the present study, we also found a correlation between NLR and plasma KYNA concentration in patients anaesthetised intravenously. Based on these findings, we can propose KYNA as a marker of inflammation.</p><p>Several volatile anaesthetics may exert anti-inflammatory effects when administered before or just after injury. They affect the interaction between neutrophils and endothelium, reducing the levels of TNF-&#x003b1; and IL-6 in human endothelial cells (Forrest et al. <xref ref-type="bibr" rid="CR20">2010</xref>; Homi et al. <xref ref-type="bibr" rid="CR29">2010</xref>; van Harten et al. <xref ref-type="bibr" rid="CR63">2012</xref>; Yue et al. <xref ref-type="bibr" rid="CR66">2008</xref>). Some experimental studies have shown a significant reduction of inflammatory mediators, chemotaxis and neutrophil adherence in a model of acute lung injury (van Harten et al. <xref ref-type="bibr" rid="CR63">2012</xref>). Inhalation of SEV decreases TNF-&#x003b1;, IL-6 and IL-8 in human cells and in rat lung (Rodr&#x000ed;uez-Gonz&#x000e1;lez et al. <xref ref-type="bibr" rid="CR48">2013</xref>; Song et al. <xref ref-type="bibr" rid="CR56">2013</xref>; Watanabe et al. <xref ref-type="bibr" rid="CR65">2013</xref>; Yue et al. <xref ref-type="bibr" rid="CR66">2008</xref>). Moreover, inhalation of SEV significantly reduces IFN-&#x003b3; production in mice (Polak et al. <xref ref-type="bibr" rid="CR46">2012</xref>). Similarly, isoflurane inhibits the aforementioned proinflammatory cytokine production in lung tissue and suppresses apoptosis by downregulating procaspases 3 and 8 and caspases 3 and 8 (Li et al. <xref ref-type="bibr" rid="CR38">2013b</xref>). Notably, both SEV and isoflurane ameliorate inflammation, but SEV is significantly more inhibitory than isoflurane in this respect (Bedirli et al. <xref ref-type="bibr" rid="CR3">2012</xref>).</p><p>It seems that the elevation in plasma KYNA may also result from the severity of CPB-related cardiac dysfunction. KYNA content correlates with severity of cardiac failure (Ristagno et al. <xref ref-type="bibr" rid="CR47">2013</xref>). In the present study, plasma KYNA increased in patients who were anaesthetised intravenously and were not subjected to SEV. It started immediately after the surgery and persisted for 72 postoperative hours. Similarly, the postoperative myocardial stunning, which occurs in more than 90&#x000a0;% of patients undergoing CPB, persists for 72 postoperative hours and clinically manifests by low cardiac output, frequently requiring pharmacologic or mechanical support (Domanski et al. <xref ref-type="bibr" rid="CR18">2011</xref>; Kinoshita and Asai <xref ref-type="bibr" rid="CR34">2012</xref>; Malik et al. <xref ref-type="bibr" rid="CR41">2006</xref>). There is also evidence that the use of SEV markedly reduces the postoperative cardiac dysfunction and improves its haemodynamic function (Lango and Mrozi&#x00144;ski <xref ref-type="bibr" rid="CR35">2010</xref>; Soro et al. <xref ref-type="bibr" rid="CR57">2012</xref>). Likewise, in our patients receiving SEV, no changes in plasma levels of KYNA were observed. Thus, we can speculate that SEV-related improvement in cardiac function affects plasma KYNA concentration, but this potential relationship should be confirmed in the future.</p><p>It is noteworthy that volatile anaesthetics reduce ischemic brain damage and improve the neurologic outcome (Brosnan and Thiesen <xref ref-type="bibr" rid="CR8">2012</xref>; Ding et al. <xref ref-type="bibr" rid="CR17">2009</xref>; Liu et al. <xref ref-type="bibr" rid="CR39">2013</xref>; Mackay et al. <xref ref-type="bibr" rid="CR40">2006</xref>; Schefold et al. <xref ref-type="bibr" rid="CR52">2009</xref>). They stabilise cerebral blood flow, improve ischemia-injured blood&#x02013;brain barrier integrity and stabilise cell membranes in brain tissue and reduce glial damage (Ding et al. <xref ref-type="bibr" rid="CR17">2009</xref>; Heyes et al. <xref ref-type="bibr" rid="CR27">1992</xref>; Schefold et al. <xref ref-type="bibr" rid="CR52">2009</xref>). Additionally, SEV inhibits <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptors and nicotinic acetylcholine receptors in a dose-dependent manner (Brosnan and Thiesen <xref ref-type="bibr" rid="CR8">2012</xref>; Ding et al. <xref ref-type="bibr" rid="CR17">2009</xref>). KYNA inhibits the same receptors (Bender <xref ref-type="bibr" rid="CR4">1982</xref>; N&#x000e9;math et al. <xref ref-type="bibr" rid="CR43">2005</xref>; Stone et al. <xref ref-type="bibr" rid="CR58">2003</xref>). Inhalation of SEV or isoflurane reduces perioperative brain injury (Dabrowski et al. <xref ref-type="bibr" rid="CR12">2010</xref>, <xref ref-type="bibr" rid="CR13">2012</xref>). Plasma KYNA concentration correlates with postoperative neuropsychological deficits in cardiac surgery patients (Forrest et al. <xref ref-type="bibr" rid="CR21">2011</xref>). An increase in plasma KYNA observed in patients with cerebral ischemia correlates with infarct volume (Brouns et al. <xref ref-type="bibr" rid="CR9">2010</xref>; Darlington et al. <xref ref-type="bibr" rid="CR15">2007</xref>). Volatile anaesthetics improve postoperative outcome in cardiac surgery patients (Kanbak et al. <xref ref-type="bibr" rid="CR31">2007</xref>; R&#x000f6;rtgen et al. <xref ref-type="bibr" rid="CR49">2010</xref>).</p><p>In summary, this is the first study documenting an increase of plasma KYNA in CPB patients and the effect of anaesthesia on KYNA. An increase in plasma KYNA correlates with severity of inflammation as measured by NLR. Our results suggest that SEV prevents the elevation of KYNA, most likely due to its anti-inflammatory properties. Based on our findings, KYNA can be used as a marker that directly correlates with the severity of inflammation in cardiac surgery patients.</p></sec></body><back><ack><p>The authors would like to thank Prof. Waldemar A. Turski (Department of Clinical and Experimental Pharmacology Medical University of Lublin, Poland), for his valuable suggestions and for sharing his expertise during the preparation of this manuscript.</p><sec id="d30e1163"><title>Conflict of interest</title><p>All authors declare that there is no conflict of interests regarding the publication of this article.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Linde-Zwirble</surname><given-names>WT</given-names></name><name><surname>Lidicker</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care</article-title><source>Crit Care Med</source><year>2001</year><volume>29</volume><fpage>1303</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1097/00003246-200107000-00002</pub-id><pub-id pub-id-type="pmid">11445675</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Shariff</surname><given-names>MA</given-names></name><name><surname>Bachir</surname><given-names>R</given-names></name><etal/></person-group><article-title>Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy</article-title><source>J Cardiothorac Surg</source><year>2013</year><volume>8</volume><fpage>193</fpage><pub-id pub-id-type="doi">10.1186/1749-8090-8-193</pub-id><pub-id pub-id-type="pmid">24070055</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedirli</surname><given-names>N</given-names></name><name><surname>Bagriacik</surname><given-names>EU</given-names></name><name><surname>Emmez</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia</article-title><source>J Neurosurg Anesthesiol</source><year>2012</year><volume>24</volume><fpage>336</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1097/ANA.0b013e318266791e</pub-id><pub-id pub-id-type="pmid">22871953</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>DA</given-names></name></person-group><article-title>Biochemistry of tryptophan in health and disease</article-title><source>Mol Aspects Med</source><year>1982</year><volume>6</volume><fpage>101</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/0098-2997(83)90005-5</pub-id><pub-id pub-id-type="pmid">6371429</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>FE</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name></person-group><article-title>Volatile anesthetics-induced neuroinflammatory and anti-inflammatory responses</article-title><source>Med Gas Res</source><year>2013</year><volume>3</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/2045-9912-3-16</pub-id><pub-id pub-id-type="pmid">23915963</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boasso</surname><given-names>A</given-names></name><name><surname>Hardy</surname><given-names>AW</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name><etal/></person-group><article-title>HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2961</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002961</pub-id><pub-id pub-id-type="pmid">18698365</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braidy</surname><given-names>N</given-names></name><name><surname>Guillemin</surname><given-names>GJ</given-names></name><name><surname>Mansour</surname><given-names>H</given-names></name><etal/></person-group><article-title>Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats</article-title><source>FEBS J</source><year>2011</year><volume>278</volume><fpage>4425</fpage><lpage>4434</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08366.x</pub-id><pub-id pub-id-type="pmid">22032336</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>RJ</given-names></name><name><surname>Thiesen</surname><given-names>R</given-names></name></person-group><article-title>Increased NMDA receptor inhibition at an increased sevoflurane MAC</article-title><source>BMC Anesthesiol</source><year>2012</year><volume>12</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/1471-2253-12-9</pub-id><pub-id pub-id-type="pmid">22672766</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouns</surname><given-names>R</given-names></name><name><surname>Verkerk</surname><given-names>R</given-names></name><name><surname>Aerts</surname><given-names>T</given-names></name><etal/></person-group><article-title>The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke</article-title><source>Neurochem Res</source><year>2010</year><volume>35</volume><fpage>1315</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1007/s11064-010-0187-2</pub-id><pub-id pub-id-type="pmid">20490917</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiapelli</surname><given-names>J</given-names></name><name><surname>Pocivavsek</surname><given-names>A</given-names></name><name><surname>Nuget</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance</article-title><source>JAMA Psychiatry</source><year>2014</year><volume>71</volume><fpage>761</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.243</pub-id><pub-id pub-id-type="pmid">24806441</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codaccioni</surname><given-names>JL</given-names></name><name><surname>Velly</surname><given-names>LJ</given-names></name><name><surname>Moubarik</surname><given-names>C</given-names></name><etal/></person-group><article-title>Sevoflurane preconditioning against focal cerebral ischemia</article-title><source>Anesthesiology</source><year>2009</year><volume>110</volume><fpage>1271</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181a1fe68</pub-id><pub-id pub-id-type="pmid">19417596</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabrowski</surname><given-names>W</given-names></name><name><surname>Rzecki</surname><given-names>Z</given-names></name><name><surname>Wosko</surname><given-names>J</given-names></name><etal/></person-group><article-title>Volatile anaesthetics reduce serum S100 concentrations in patients undergoing elective cardiac surgery</article-title><source>Appl Cardiopulmonary Pathophysiol</source><year>2010</year><volume>14</volume><fpage>139</fpage><lpage>148</lpage></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabrowski</surname><given-names>W</given-names></name><name><surname>Rzecki</surname><given-names>Z</given-names></name><name><surname>Czajkowski</surname><given-names>M</given-names></name><etal/></person-group><article-title>Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2012</year><volume>26</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2011.10.014</pub-id><pub-id pub-id-type="pmid">22206712</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabrowski</surname><given-names>W</given-names></name><name><surname>Kocki</surname><given-names>T</given-names></name><name><surname>Pilat</surname><given-names>J</given-names></name><etal/></person-group><article-title>Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration</article-title><source>Inflammation</source><year>2014</year><volume>37</volume><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1007/s10753-013-9733-9</pub-id><pub-id pub-id-type="pmid">24043287</pub-id></element-citation></ref><ref id="CR15"><mixed-citation publication-type="other">Darlington LG, Mackay GM, Forrest CM et al (2007) Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26(8):2211&#x02013;2221</mixed-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jager</surname><given-names>CP</given-names></name><name><surname>van Wijk</surname><given-names>PT</given-names></name><name><surname>Mathoera</surname><given-names>RB</given-names></name><etal/></person-group><article-title>Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit</article-title><source>Crit Care</source><year>2010</year><volume>14</volume><fpage>R192</fpage><pub-id pub-id-type="doi">10.1186/cc9309</pub-id><pub-id pub-id-type="pmid">21034463</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits</article-title><source>Anesth Analg</source><year>2009</year><volume>109</volume><fpage>1263</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1213/ane.0b013e3181b2214c</pub-id><pub-id pub-id-type="pmid">19762756</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domanski</surname><given-names>MJ</given-names></name><name><surname>Mahaffey</surname><given-names>K</given-names></name><name><surname>Hasselblad</surname><given-names>V</given-names></name><etal/></person-group><article-title>Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery</article-title><source>JAMA</source><year>2011</year><volume>305</volume><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.99</pub-id><pub-id pub-id-type="pmid">21304084</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>CM</given-names></name><name><surname>Mackay</surname><given-names>GM</given-names></name><name><surname>Oxford</surname><given-names>L</given-names></name><etal/></person-group><article-title>Kynurenine pathway metabolism in patients with osteoporosis after 2&#x000a0;years of drug treatment</article-title><source>Clin Exp Pharmacol Physiol</source><year>2006</year><volume>33</volume><fpage>1078</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2006.04490.x</pub-id><pub-id pub-id-type="pmid">17042918</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>CM</given-names></name><name><surname>Mackay</surname><given-names>GM</given-names></name><name><surname>Stoy</surname><given-names>N</given-names></name><etal/></person-group><article-title>Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington&#x02019;s disease</article-title><source>J Neurochem</source><year>2010</year><volume>112</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06442.x</pub-id><pub-id pub-id-type="pmid">19845828</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>CM</given-names></name><name><surname>Mackay</surname><given-names>GM</given-names></name><name><surname>Oxford</surname><given-names>L</given-names></name><etal/></person-group><article-title>Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery</article-title><source>J Neurochem</source><year>2011</year><volume>119</volume><fpage>136</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07414.x</pub-id><pub-id pub-id-type="pmid">21819405</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gell&#x000e9;rt</surname><given-names>L</given-names></name><name><surname>Knapp</surname><given-names>L</given-names></name><name><surname>N&#x000e9;meth</surname><given-names>K</given-names></name><etal/></person-group><article-title>Post-ischemic treatment with L-kynurenine sulfate exacerbates neuronal damage after transient middle cerebral artery occlusion</article-title><source>Neuroscience</source><year>2013</year><volume>247</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.04.063</pub-id><pub-id pub-id-type="pmid">23685169</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>PH</given-names></name><name><surname>Croal</surname><given-names>BL</given-names></name><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting</article-title><source>Am Heart J</source><year>2007</year><volume>154</volume><fpage>995</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2007.06.043</pub-id><pub-id pub-id-type="pmid">17967611</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>PH</given-names></name><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><name><surname>Croal</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting</article-title><source>Am J Cardiol</source><year>2010</year><volume>105</volume><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2009.09.007</pub-id><pub-id pub-id-type="pmid">20102916</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gokcinar</surname><given-names>D</given-names></name><name><surname>Ergin</surname><given-names>V</given-names></name><name><surname>Cumaoglu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury</article-title><source>Acta Biochim Pol</source><year>2013</year><volume>60</volume><fpage>451</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">24020061</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartai</surname><given-names>Z</given-names></name><name><surname>Juh&#x000e1;sz</surname><given-names>A</given-names></name><name><surname>Riman&#x000f3;czy</surname><given-names>&#x000c1;</given-names></name><etal/></person-group><article-title>Decreased serum and red blood cell kynurenic acid levels in Alzheimer&#x02019;s disease</article-title><source>Neurochem Int</source><year>2007</year><volume>50</volume><fpage>308</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2006.08.012</pub-id><pub-id pub-id-type="pmid">17023091</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyes</surname><given-names>MP</given-names></name><name><surname>Brew</surname><given-names>BJ</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients</article-title><source>J Neuroimmunol</source><year>1992</year><volume>40</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/0165-5728(92)90214-6</pub-id><pub-id pub-id-type="pmid">1387655</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofstetter</surname><given-names>C</given-names></name><name><surname>Boost</surname><given-names>KA</given-names></name><name><surname>Flondor</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats</article-title><source>Acta Anaesthesiol Scand</source><year>2007</year><volume>51</volume><fpage>893</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2007.01353.x</pub-id><pub-id pub-id-type="pmid">17635397</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homi</surname><given-names>HM</given-names></name><name><surname>Jones</surname><given-names>WL</given-names></name><name><surname>de Lange</surname><given-names>F</given-names></name><etal/></person-group><article-title>Exacerbation of systemic inflammation and increased cerebral infarct volume with cardiopulmonary bypass after focal cerebral ischemia in the rat</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>140</volume><fpage>660</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2009.10.063</pub-id><pub-id pub-id-type="pmid">20236669</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Comparison of the sequential organ failure assessment, acute physiology and chronic health evaluation II scoring system, and trauma and injury severity score method for predicting the outcomes of intensive care unit trauma patients</article-title><source>Am J Emerg Med</source><year>2012</year><volume>30</volume><fpage>749</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2011.05.022</pub-id><pub-id pub-id-type="pmid">21802884</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanbak</surname><given-names>M</given-names></name><name><surname>Saricaoglu</surname><given-names>F</given-names></name><name><surname>Akinci</surname><given-names>SB</given-names></name><etal/></person-group><article-title>The effects of isoflurane, sevoflurane, and desflurane anesthesia on neurocognitive outcome after cardiac surgery: a pilot study</article-title><source>Heart Surg Forum</source><year>2007</year><volume>10</volume><fpage>E36</fpage><lpage>E41</lpage><pub-id pub-id-type="doi">10.1532/HSF98.20061076</pub-id><pub-id pub-id-type="pmid">17162400</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidani</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kanakura</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sevoflurane pretreatment inhibits endotoxin-induced shock in rats</article-title><source>Anesth Analg</source><year>2005</year><volume>101</volume><fpage>1152</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1213/01.ane.0000167768.55939.e1</pub-id><pub-id pub-id-type="pmid">16192536</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><etal/></person-group><article-title>Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury</article-title><source>Anesthesiology</source><year>2011</year><volume>114</volume><fpage>363</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3182070c3a</pub-id><pub-id pub-id-type="pmid">21245730</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Asai</surname><given-names>T</given-names></name></person-group><article-title>Preservation of myocardium during coronary artery bypass surgery</article-title><source>Curr Cardiol Rep</source><year>2012</year><volume>14</volume><fpage>418</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s11886-012-0271-0</pub-id><pub-id pub-id-type="pmid">22528557</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lango</surname><given-names>R</given-names></name><name><surname>Mrozi&#x00144;ski</surname><given-names>P</given-names></name></person-group><article-title>Clinical importance of anaesthetic preconditioning</article-title><source>Anestezjol Intens Ter</source><year>2010</year><volume>42</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">21252838</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laupland</surname><given-names>KB</given-names></name><name><surname>Davies</surname><given-names>HD</given-names></name><name><surname>Church</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study</article-title><source>Infection</source><year>2004</year><volume>32</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1007/s15010-004-3064-6</pub-id><pub-id pub-id-type="pmid">15057568</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice</article-title><source>Neurobiol Dis</source><year>2013</year><volume>54</volume><fpage>216</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.12.014</pub-id><pub-id pub-id-type="pmid">23313315</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JT</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis</article-title><source>Mediators Inflamm</source><year>2013</year><volume>2013</volume><fpage>108928</fpage><pub-id pub-id-type="pmid">23710113</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><etal/></person-group><article-title>Synergistic effect of sevoflurane and isoflurane on inhibition of the adult-type muscle nicotinic acetylcholine receptor by rocuronium</article-title><source>J Anesth</source><year>2013</year><volume>27</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1007/s00540-012-1527-y</pub-id><pub-id pub-id-type="pmid">23238810</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>GM</given-names></name><name><surname>Forrest</surname><given-names>CM</given-names></name><name><surname>Stoy</surname><given-names>N</given-names></name><etal/></person-group><article-title>Tryptophan metabolism and oxidative stress in patients with chronic brain injury</article-title><source>Eur J Neurol</source><year>2006</year><volume>13</volume><fpage>30</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.2006.01220.x</pub-id><pub-id pub-id-type="pmid">16420391</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>V</given-names></name><name><surname>Kale</surname><given-names>SC</given-names></name><name><surname>Chowdhury</surname><given-names>UK</given-names></name><etal/></person-group><article-title>Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release</article-title><source>Tex Heart Inst J</source><year>2006</year><volume>33</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">17041689</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marfella</surname><given-names>A</given-names></name><name><surname>Bilancio</surname><given-names>A</given-names></name><name><surname>Polese</surname><given-names>C</given-names></name><etal/></person-group><article-title>Urinary neopterin and kynurenine in patients submitted to surgical stress with different inhalational anesthetics (halothane or isoflurane)</article-title><source>Int J Immunopharmacol</source><year>1999</year><volume>21</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/S0192-0561(99)00021-1</pub-id><pub-id pub-id-type="pmid">10454016</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000e9;math</surname><given-names>H</given-names></name><name><surname>Toldi</surname><given-names>J</given-names></name><name><surname>V&#x000e9;csei</surname><given-names>L</given-names></name></person-group><article-title>Role of kynurenines in the central and peripheral nervous system</article-title><source>Curr Neurovasc Res</source><year>2005</year><volume>2</volume><fpage>249</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.2174/1567202054368326</pub-id><pub-id pub-id-type="pmid">16181118</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>LK</given-names></name><name><surname>Linderholm</surname><given-names>KR</given-names></name><name><surname>Engberg</surname><given-names>G</given-names></name><etal/></person-group><article-title>Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia</article-title><source>Schizophr Res</source><year>2005</year><volume>80</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2005.07.013</pub-id><pub-id pub-id-type="pmid">16125901</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ploder</surname><given-names>M</given-names></name><name><surname>Spittler</surname><given-names>A</given-names></name><name><surname>Schroecksanadel</surname><given-names>K</given-names></name><etal/></person-group><article-title>Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors</article-title><source>Clin Sci</source><year>2009</year><volume>116</volume><fpage>593</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1042/CS20080319</pub-id><pub-id pub-id-type="pmid">18986303</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polak</surname><given-names>PE</given-names></name><name><surname>Dull</surname><given-names>RO</given-names></name><name><surname>Kalinin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis</article-title><source>J Neuroinflammation</source><year>2012</year><volume>9</volume><fpage>272</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-9-272</pub-id><pub-id pub-id-type="pmid">23253693</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristagno</surname><given-names>G</given-names></name><name><surname>Fries</surname><given-names>M</given-names></name><name><surname>Brunelli</surname><given-names>L</given-names></name><etal/></person-group><article-title>Early kynurenine pathway activation following cardiac arrest in rats, pigs, and humans</article-title><source>Resuscitation</source><year>2013</year><volume>84</volume><fpage>1604</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1016/j.resuscitation.2013.06.002</pub-id><pub-id pub-id-type="pmid">23774325</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;uez-Gonz&#x000e1;lez</surname><given-names>R</given-names></name><name><surname>Baluja</surname><given-names>A</given-names></name><name><surname>Veiras Del R&#x000ed;o</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of sevoflurane postconditioning on call death, inflammation and TLR expression in human endothelial cells exposed to LPS</article-title><source>J Transl Med</source><year>2013</year><volume>11</volume><fpage>87</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-11-87</pub-id><pub-id pub-id-type="pmid">23552565</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;rtgen</surname><given-names>D</given-names></name><name><surname>Kloos</surname><given-names>J</given-names></name><name><surname>Fries</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of early cognitive function and recovery after desflurane or sevoflurane anaesthesia in the elderly: a double-blinded randomized controlled trial</article-title><source>Br J Anaesth</source><year>2010</year><volume>104</volume><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1093/bja/aep369</pub-id><pub-id pub-id-type="pmid">20042477</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruddick</surname><given-names>JP</given-names></name><name><surname>Evans</surname><given-names>AK</given-names></name><name><surname>Nutt</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Tryptophan metabolism in the central nervous system: medical implications</article-title><source>Expert Rev Mol Med</source><year>2006</year><volume>8</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1017/S1462399406000068</pub-id><pub-id pub-id-type="pmid">16942634</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sas</surname><given-names>K</given-names></name><name><surname>Robotka</surname><given-names>H</given-names></name><name><surname>R&#x000f3;zsa</surname><given-names>E</given-names></name><etal/></person-group><article-title>Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus</article-title><source>Neurobiol Dis</source><year>2008</year><volume>32</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2008.07.013</pub-id><pub-id pub-id-type="pmid">18761090</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schefold</surname><given-names>JC</given-names></name><name><surname>Zeden</surname><given-names>JP</given-names></name><name><surname>Fotopoulou</surname><given-names>C</given-names></name><etal/></person-group><article-title>Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms</article-title><source>Nephrol Dial Transplant</source><year>2009</year><volume>24</volume><fpage>1901</fpage><lpage>1908</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfn739</pub-id><pub-id pub-id-type="pmid">19155537</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>GN</given-names></name><name><surname>DuHadaway</surname><given-names>J</given-names></name><name><surname>Pigott</surname><given-names>E</given-names></name><etal/></person-group><article-title>The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><fpage>7509</fpage><lpage>7517</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0804328</pub-id><pub-id pub-id-type="pmid">19494274</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>K</given-names></name></person-group><article-title>Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography</article-title><source>J Chromatogr</source><year>1988</year><volume>430</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/S0378-4347(00)83173-4</pub-id><pub-id pub-id-type="pmid">3235510</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiny</surname><given-names>A</given-names></name><name><surname>Bibin</surname><given-names>YS</given-names></name><name><surname>Shanthirani</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes</article-title><source>Diabetes Technol Ther</source><year>2014</year><volume>16</volume><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1089/dia.2013.0264</pub-id><pub-id pub-id-type="pmid">24455985</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SY</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Preventive effects of sevoflurane treatment on lung inflammation in rats</article-title><source>Asian Pac J Trop Med</source><year>2013</year><volume>6</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S1995-7645(12)60200-4</pub-id><pub-id pub-id-type="pmid">23317886</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soro</surname><given-names>M</given-names></name><name><surname>Gallego</surname><given-names>L</given-names></name><name><surname>Silva</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomised study</article-title><source>Eur J Anaesthesiol</source><year>2012</year><volume>29</volume><fpage>561</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1097/EJA.0b013e3283560aea</pub-id><pub-id pub-id-type="pmid">22965457</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>TW</given-names></name><name><surname>Mackay</surname><given-names>GM</given-names></name><name><surname>Forrest</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Tryptophan metabolites and brain disorders</article-title><source>Clin Chem Lab Med</source><year>2003</year><volume>7</volume><fpage>852</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">12940508</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Symons</surname><given-names>JA</given-names></name><name><surname>Myles</surname><given-names>PS</given-names></name></person-group><article-title>Myocardial protection with volatile anesthetic agents during coronary artery bypass surgery: a meta-analysis</article-title><source>Br J Anaesth</source><year>2006</year><volume>97</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1093/bja/ael149</pub-id><pub-id pub-id-type="pmid">16793778</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terlecki</surname><given-names>P</given-names></name><name><surname>Pawlik</surname><given-names>P</given-names></name><name><surname>Iwaniuk</surname><given-names>A</given-names></name><etal/></person-group><article-title>Carotid surgery affects plasma kynurenic acid concentration: a pilot study</article-title><source>Med Sci Monit</source><year>2014</year><volume>20</volume><fpage>303</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.12659/MSM.890212</pub-id><pub-id pub-id-type="pmid">24561546</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thal</surname><given-names>SC</given-names></name><name><surname>Luh</surname><given-names>C</given-names></name><name><surname>Schaible</surname><given-names>EV</given-names></name><etal/></person-group><article-title>Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e50752</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0050752</pub-id><pub-id pub-id-type="pmid">23251381</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turski</surname><given-names>MP</given-names></name><name><surname>Turska</surname><given-names>M</given-names></name><name><surname>Paluszkiewicz</surname><given-names>P</given-names></name><etal/></person-group><article-title>Kynurenic acid in the digestive system: new facts, new challenges</article-title><source>Int J Tryptophan Res</source><year>2013</year><volume>6</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">24049450</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Harten</surname><given-names>AE</given-names></name><name><surname>Scheeren</surname><given-names>TW</given-names></name><name><surname>Absalom</surname><given-names>AR</given-names></name></person-group><article-title>A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia</article-title><source>Anaesthesia</source><year>2012</year><volume>67</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2044.2011.07008.x</pub-id><pub-id pub-id-type="pmid">22321085</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>ZG</given-names></name><name><surname>Dong</surname><given-names>XW</given-names></name><etal/></person-group><article-title>Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase</article-title><source>Neurosci Bull</source><year>2010</year><volume>26</volume><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1007/s12264-010-6024-4</pub-id><pub-id pub-id-type="pmid">21113194</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Iwahara</surname><given-names>C</given-names></name><name><surname>Nakayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sevoflurane suppresses tumour necrosis factor-&#x003b1;-induced inflammatory responses in small airway epithelial cells after anoxia/reoxygenation</article-title><source>Br J Anaesth</source><year>2013</year><volume>110</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1093/bja/aes469</pub-id><pub-id pub-id-type="pmid">23295714</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>T</given-names></name><name><surname>Rot Z&#x02019;graggen</surname><given-names>B</given-names></name><name><surname>Blumenthal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro</article-title><source>Eur Respir J</source><year>2008</year><volume>31</volume><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1183/09031936.00046307</pub-id><pub-id pub-id-type="pmid">17898018</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahorec</surname><given-names>R</given-names></name></person-group><article-title>Ratio of neutrophil to lymphocyte counts&#x02013;rapid and simple parameter of systemic inflammation and stress in critically ill</article-title><source>Bratisl Lek Listy</source><year>2001</year><volume>102</volume><fpage>5</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11723675</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeden</surname><given-names>JP</given-names></name><name><surname>Fusch</surname><given-names>G</given-names></name><name><surname>Holtfreter</surname><given-names>B</given-names></name><etal/></person-group><article-title>Excessive tryptophan catabolism along the kynurenine pathway precedes ongoing sepsis in critically ill patients</article-title><source>Anaesth Intensive Care</source><year>2010</year><volume>38</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">20369765</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zitta</surname><given-names>K</given-names></name><name><surname>Meybohm</surname><given-names>P</given-names></name><name><surname>Bein</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in vitro hypoxia model</article-title><source>Eur J Pharmacol</source><year>2010</year><volume>645</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2010.07.017</pub-id><pub-id pub-id-type="pmid">20655305</pub-id></element-citation></ref></ref-list></back></article>